INDmoney
Ligand Pharmaceuticals Incorporated Stock Performance
as on March 4, 2026 at 7:08 am IST
Day's Low
Day's High
$198.00$206.08
3.20%
Downside
0.75%
Upside
52 Week's Low
52 Week's High
$93.58$212.4954.25%
Downside
3.89%
Upside
Ligand Pharmaceuticals Incorporated share price movements today
- Previous Close
- $202.55
- Open
- $198.00
- Volume
- 212.6K
- Day's Low - High
- $198.00 - $206.08
- 52 Week Low - High
- $93.58 - $212.49
Ligand Pharmaceuticals Incorporated Historical Returns
- 1 Month Return
- + 1.87 %
- 3 Month Return
- + 4.93 %
- 1 Year Return
- + 80.56 %
- 3 Year Return
- + 162.78 %
- 5 Year Return
- + 37.05 %
Ligand Pharmaceuticals Incorporated Stock Fundamentals & Key Indicators
Check Ligand Pharmaceuticals Incorporated market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$3.9B
EPS (TTM)
8.45
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
1.03%
PE Ratio (TTM)
86.98
Industry PE ratio
-3.105112781954887
PEG Ratio
1.5271
EBITDA
81.3M
Revenue (TTM)
268.1M
Profit Margin
46.42%
Return On Equity TTM
13.47%
Ligand Pharmaceuticals Incorporated Stock Valuation
Track how Ligand Pharmaceuticals Incorporated P/E has moved over time to understand its valuation trends.
Ligand Pharmaceuticals Incorporated in the last 5 years
Lowest (9.67x)
December 31, 2023
Industry (-3.11x)
March 3, 2026
Today (86.98x)
March 3, 2026
Highest (29.89x)
March 31, 2021
Today’s Price to Earnings Ratio: 86.98x
Ligand Pharmaceuticals Incorporated vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Ligand Pharmaceuticals Incorporated with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $3.9B | 37.05% | 86.98 | 46.42% | |
| BUY | $126.2B | 133.18% | 32.47 | 32.94% | |
| BUY | $44.2B | 125.24% | 142.88 | 8.45% | |
| NA | $35.1B | NA | 621.55 | 5.37% | |
| BUY | $82.6B | 77.02% | 18.83 | 31.41% |
Stock Returns calculator for Ligand Pharmaceuticals Incorporated Stock including INR - Dollar returns
The Ligand Pharmaceuticals Incorporated stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Ligand Pharmaceuticals Incorporated investment value today
Current value as on today
₹1,87,837
Returns
₹87,837
(+87.84%)
Returns from Ligand Pharmaceuticals Incorporated Stock
₹82,332 (+82.33%)
Dollar Returns*
₹5,505 (+5.5%)
Analyst Recommendation on Ligand Pharmaceuticals Incorporated Stock
Based on 11 analysts
90.91%
Buy
9.09%
Hold
0.00%
Sell
Based on 11 analysts, 90.91% of analysts recommend a 'BUY' rating for Ligand Pharmaceuticals Incorporated. Average target price of $244.56
Ligand Pharmaceuticals Incorporated Share Price Target
Get share price movements and forecasts by analysts on Ligand Pharmaceuticals Incorporated.
What analysts predicted
16.36%UPSIDE
Target Price
$244.56
Current Price
$204.54
Analyzed by
11 Analysts
Target
$244.56
Ligand Pharmaceuticals Incorporated target price $244.56, a slight upside of 16.36% compared to current price of $204.54. According to 11 analysts rating.
Ligand Pharmaceuticals Incorporated Stock’s Investor Sentiment and Interest
Search interest for Ligand Pharmaceuticals Incorporated Stock has increased by 180% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:180% versus previous 30 day period
Ligand Pharmaceuticals Incorporated Quarterly Profit & Loss
All numbers in Millions USD
Ligand Pharmaceuticals Incorporated Annual Profit & Loss
All numbers in Millions USD
Ligand Pharmaceuticals Incorporated Quarterly Cash Flow
All numbers in Millions USD
Ligand Pharmaceuticals Incorporated Annual Cash Flow
All numbers in Millions USD
Insights on Ligand Pharmaceuticals Incorporated
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTBest in 3 Years
In the last 3 years, LGND has outperformed top 5 stocks with highest market-cap in its industry
- POSITIVE IMPACT
Price Rise
In the last 3 years, LGND stock has moved up by 162.8%
- POSITIVE IMPACT
Best in 1 Year
In the last 1 year, LGND has outperformed top 5 stocks with highest market-cap in its industry
NEGATIVE IMPACTRevenue Fall
Revenue is down for the last 2 quarters, 115.46M → 59.66M (in $), with an average decrease of 48.3% per quarter
- NEGATIVE IMPACT
Profit Down
Netprofit is down for the last 2 quarters, 117.27M → 44.78M (in $), with an average decrease of 61.8% per quarter
About Ligand Pharmaceuticals Incorporated
| Organisation | Ligand Pharmaceuticals Incorporated |
| Headquarters | 555 Heritage Drive, Jupiter, FL, United States, 33458 |
| Industry | Health Technology |
| CEO | Mr. Todd C. Davis Ph.D. |
| E-voting on shares | Click here to vote |
Key Management of Ligand Pharmaceuticals Incorporated
Name | Title |
|---|---|
Mr. Patrick Lucy | Senior VP & CBO Protein Expression Business |
Mr. Richard B. Baxter | Senior VP of Investment Operation |
Mr. Octavio Espinoza | Chief Financial Officer |
Mr. Andrew T. Reardon J.D. | Chief Legal Officer & Secretary |
Dr. Keith Marschke Ph.D. | Senior Vice President of Biology & Scientific Affairs |
Dr. Vincent D. Antle Ph.D. | Senior Vice President of Technical Operations & QA - Capitsol |
Dr. Karen R. Reeves M.D. | Senior VP of Investments & Head of Clinical Strategy |
Mr. Todd C. Davis Ph.D. | CEO & Director |
Mr. Paul J. Hadden | Senior Vice President of Investments & Business Development |
Ms. Melanie J. Herman CPA | Executive Director of Investor Relations and FP&A |
FAQs
What is Ligand Pharmaceuticals Incorporated share price today?
Ligand Pharmaceuticals Incorporated share price today is $204.54 as on . Ligand Pharmaceuticals Incorporated share today touched a day high of $206.08 and a low of $198.
What is the 52 week high and 52 week low for Ligand Pharmaceuticals Incorporated share?
Ligand Pharmaceuticals Incorporated share touched a 52 week high of $212.49 on and a 52 week low of $93.58 on . Ligand Pharmaceuticals Incorporated stock price today i.e. is trending at $204.54,which is 3.74% down from its 52 week high and 118.57% up from its 52 week low.
What is Ligand Pharmaceuticals Incorporated's market capitalisation today?
Ligand Pharmaceuticals Incorporated market capitalisation is $0.00T as on .
How to invest in Ligand Pharmaceuticals Incorporated Stock (LGND) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Ligand Pharmaceuticals Incorporated on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Ligand Pharmaceuticals Incorporated Shares that will get you 0.0073 shares as per Ligand Pharmaceuticals Incorporated share price of $204.54 per share as on March 4, 2026 at 1:38 am IST.
What is the minimum amount required to buy Ligand Pharmaceuticals Incorporated Stock (LGND) from India?
Indian investors can start investing in Ligand Pharmaceuticals Incorporated (LGND) shares with as little as ₹92.074 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹920.74 in Ligand Pharmaceuticals Incorporated stock (as per the Rupee-Dollar exchange rate as on ).
Based on Ligand Pharmaceuticals Incorporated share’s latest price of $204.54 as on March 4, 2026 at 1:38 am IST, you will get 0.0489 shares of Ligand Pharmaceuticals Incorporated. Learn more about
fractional shares .
What are the returns that Ligand Pharmaceuticals Incorporated has given to Indian investors in the last 5 years?
Ligand Pharmaceuticals Incorporated stock has given 37.05% share price returns and 25.56% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?